Jen JF - Search Results

1

Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C.

Jen JF, Glue P, Ezzet F, Chung C, Gupta SK, Jacobs S, Hajian G. Jen JF, et al. Clin Pharmacol Ther. 2001 Jun;69(6):407-21. doi: 10.1067/mcp.2001.115872. Clin Pharmacol Ther. 2001. PMID: 11406738 Clinical Trial.

2

Ribavirin dosing in chronic hepatitis C: application of population pharmacokinetic-pharmacodynamic models.

Jen J, Laughlin M, Chung C, Heft S, Affrime MB, Gupta SK, Glue P, Hajian G. Jen J, et al. Clin Pharmacol Ther. 2002 Oct;72(4):349-61. doi: 10.1067/mcp.2002.127112. Clin Pharmacol Ther. 2002. PMID: 12386637

3

Dose selection and population pharmacokinetics of PEG-Intron in patients with chronic myelogenous leukaemia.

Gupta S, Jen J, Kolz K, Cutler D. Gupta S, et al. Br J Clin Pharmacol. 2007 Mar;63(3):292-9. doi: 10.1111/j.1365-2125.2006.02757.x. Epub 2006 Aug 30. Br J Clin Pharmacol. 2007. PMID: 16939523 Free PMC article. Clinical Trial.

4

Population pharmacokinetic and pharmacodynamic analysis of ribavirin in patients with chronic hepatitis C.

Jen JF, Glue P, Gupta S, Zambas D, Hajian G. Jen JF, et al. Ther Drug Monit. 2000 Oct;22(5):555-65. doi: 10.1097/00007691-200010000-00010. Ther Drug Monit. 2000. PMID: 11034261

5

Population pharmacokinetics of temozolomide in cancer patients.

Jen JF, Cutler DL, Pai SM, Batra VK, Affrime MB, Zambas DN, Heft S, Hajian G. Jen JF, et al. Pharm Res. 2000 Oct;17(10):1284-9. doi: 10.1023/a:1026403805756. Pharm Res. 2000. PMID: 11145236

6

The effect of age on the apparent clearance of felbamate: a retrospective analysis using nonlinear mixed-effects modeling.

Banfield CR, Zhu GR, Jen JF, Jensen PK, Schumaker RC, Perhach JL, Affrime MB, Glue P. Banfield CR, et al. Among authors: jen jf. Ther Drug Monit. 1996 Feb;18(1):19-29. doi: 10.1097/00007691-199602000-00004. Ther Drug Monit. 1996. PMID: 8848816 Clinical Trial.

7

Pegvisomant bioavailability of single 30 mg/mL subcutaneous injection compared to two 15 mg/mL subcutaneous injections: a pharmacokinetic, safety and tolerability study.

Jen J, LaBadie RR, Liang Y, Crownover PH, Gao X, Hey-Hadavi JH. Jen J, et al. Growth Horm IGF Res. 2013 Aug;23(4):114-9. doi: 10.1016/j.ghir.2013.04.002. Epub 2013 May 4. Growth Horm IGF Res. 2013. PMID: 23651793 Clinical Trial.

8

A sublimate sorbent for stir-bar sorptive extraction of aqueous endocrine disruptor pesticides for gas chromatography-electron capture detection.

Huang YW, Lee HK, Shih HK, Jen JF. Huang YW, et al. Among authors: jen jf. J Chromatogr A. 2018 Aug 24;1564:51-58. doi: 10.1016/j.chroma.2018.06.018. Epub 2018 Jun 6. J Chromatogr A. 2018. PMID: 29903469

9

Microwave-assisted decomplexation and in-situ headspace in-syringe dynamic derivatization of dimethylamine borane with high performance liquid chromatography-fluorescence detection.

Muniraj S, Lee HK, Hsiech C, Jen JF. Muniraj S, et al. Among authors: jen jf. J Chromatogr A. 2018 Feb 16;1537:21-26. doi: 10.1016/j.chroma.2018.01.012. Epub 2018 Jan 5. J Chromatogr A. 2018. PMID: 29373127

10

Bis(phenylidenebenzeneamine)-1-disulfide Derivatives Induce Autophagy in Melanoma Cells Through a Mitochondria-mediated Pathway.

Hu WP, Hsu CC, Wang YC, Senadi GC, Kuo KK, Jen JF, Wang JJ. Hu WP, et al. Among authors: jen jf. Anticancer Res. 2015 Nov;35(11):6075-80. Anticancer Res. 2015. PMID: 26504032

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters